Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $75,000 In Zynex To Contact Him Directly To Discuss Their Options If you suffered losses exceeding $75,000 in Zynex between March 13, 2023 and March 11, 2025 and would like to discuss your legal rights, call Faruqi & Faruqi partner Josh Wilson directly at 877-247-4292 or 212-983-9330 (Ext. 1310). [You may also click here for additional information] NEW YORK, April 13, 2025 (GLOBE NEWSWI ...

文章核心观点 Levi & Korsinsky, LLP通知Zynex, Inc.投资者有关该公司的证券集体诉讼，指控被告存在证券欺诈行为，投资者可在规定时间申请成为首席原告，且参与无成本 [1][2][3] 案件详情 - 被告虚假陈述或隐瞒情况，包括产品发货超需求、虚增收入、虚假索赔受保险公司审查、可能面临不利后果及积极陈述误导等 [2] 后续安排 - 相关时间段内受损投资者需在2025年5月19日前申请成为首席原告，不担任也可分享赔偿 [3] 律所优势 - Levi & Korsinsky过去20年为股东获数亿美元赔偿，擅长复杂证券诉讼，有超70名员工，连续7年跻身美国证券诉讼律所前50 [4] 联系方式 - 律所信息：Levi & Korsinsky, LLP，地址为33 Whitehall Street, 17th Floor, New York, NY 10004，邮箱[email protected]，电话(212) 363 - 7500，传真(212) 363 - 7171，网址www.zlk.com [5]

Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses In Zynex To Contact Him Directly To Discuss Their OptionsIf you purchased or acquired securities in Zynex between March 13, 2023 and March 11, 2025 and would like to discuss your legal rights, call Faruqi & Faruqi partner Josh Wilson directly at 877-247-4292 or 212-983-9330 (Ext. 1310).[You may also click here for additional information]NEW YORK, April 10, 2025 /PRNewswire/ -- Faruqi & Faruqi, LLP ...

PHILADELPHIA, April 10, 2025 (GLOBE NEWSWIRE) -- Berger Montague PC advises investors that a securities class action lawsuit has been filed against Zynex, Inc. (“Zynex” or the “Company”) (NASDAQ: ZYXI) on behalf of purchasers of Zynex securities between March 13, 2023 through March 11, 2025, inclusive (the “Class Period”). Investor Deadline: Investors who purchased or acquired Zynex securities during the Class Period may, no later than MAY 19, 2025, seek to be appointed as a lead plaintiff representative of ...

NEW YORK, April 10, 2025 /PRNewswire/ -- The Gross Law Firm issues the following notice to shareholders of Zynex, Inc. (NASDAQ: ZYXI).Shareholders who purchased shares of ZYXI during the class period listed are encouraged to contact the firm regarding possible lead plaintiff appointment. Appointment as lead plaintiff is not required to partake in any recovery.CONTACT US HERE:https://securitiesclasslaw.com/securities/zynex-inc-loss-submission-form/?id=141948&from=4 CLASS PERIOD: March 13, 2023 to March 11, 2 ...

PHILADELPHIA, April 9, 2025 /PRNewswire/ -- Berger Montague PC advises investors that a securities class action lawsuit has been filed against Zynex, Inc. ("Zynex" or the "Company") (NASDAQ: ZYXI) on behalf of purchasers of Zynex securities between March 13, 2023 through March 11, 2025, inclusive (the "Class Period").Investor Deadline: Investors who purchased or acquired ZYNEX securities during the Class Period may, no later than MAY 19, 2025, seek to be appointed as a lead plaintiff representative of the c ...

NEW YORK, April 8, 2025 /PRNewswire/ -- Levi & Korsinsky, LLP notifies investors in Zynex, Inc. ("Zynex, Inc." or the "Company") (NASDAQ: ZYXI) of a class action securities lawsuit.CLASS DEFINITION: The lawsuit seeks to recover losses on behalf of Zynex, Inc. investors who were adversely affected by alleged securities fraud between March 13, 2023 and March 11, 2025. Follow the link below to get more information and be contacted by a member of our team:https://zlk.com/pslra-1/zynex-inc-lawsuit-submission-for ...

NEW YORK, April 7, 2025 /PRNewswire/ -- The Gross Law Firm issues the following notice to shareholders of Zynex, Inc. (NASDAQ: ZYXI).Shareholders who purchased shares of ZYXI during the class period listed are encouraged to contact the firm regarding possible lead plaintiff appointment. Appointment as lead plaintiff is not required to partake in any recovery.CONTACT US HERE:https://securitiesclasslaw.com/securities/zynex-inc-loss-submission-form/?id=140991&from=4CLASS PERIOD: March 13, 2023 to March 11, 202 ...

Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $75,000 In Zynex To Contact Him Directly To Discuss Their Options If you suffered losses exceeding $75,000 in Zynex between March 13, 2023 and March 11, 2025 and would like to discuss your legal rights, call Faruqi & Faruqi partner Josh Wilson directly at 877-247-4292 or 212-983-9330 (Ext. 1310). [You may also click here for additional information] NEW YORK, April 06, 2025 (GLOBE NEWSWI ...

文章核心观点 - 公司通过旗舰设备NexWave提供无创、非成瘾性的家庭疼痛管理方案，以应对阿片类药物危机，销售副总裁阐述公司使命、产品特点及发展愿景 [1] 公司情况 - 销售副总裁Steve Fox有近20年销售和运营经验，涉足多个领域，因公司文化、使命和增长潜力加入 [3][4] - 公司核心是无创、非阿片类疼痛管理，约300名销售代表在美国向医疗服务提供者宣传家庭疼痛管理替代方案 [5] 产品情况 - 旗舰产品NexWave是三合一设备，包含TENS、IFC和NMES功能，适用于康复和疼痛管理，受医疗服务提供者欢迎 [6] 发展愿景 - 销售副总裁的工作是延续并扩大公司的增长，让更多医疗服务提供者了解公司，使公司家喻户晓 [7] - 目前公司主要聚焦美国市场，销售代表注重对医疗服务提供者的教育 [8] 公司文化 - 公司使命是提供家庭、无创、非成瘾性疼痛管理方案，这驱动着公司发展，所有销售代表都认同该使命 [9] 市场契合度 - 随着人口老龄化，更多人避免手术且需非阿片类疼痛管理方案，公司产品无创、非成瘾、易用，受老年群体欢迎 [10]